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Abstract
Background: MicroRNAs are short (,22 nt) non-coding regulatory RNAs that control gene expression at the post-
transcriptional level. Here the functional impact of microRNAs on cell cycle arrest during neuronal lineage differentiation of
unrestricted somatic stem cells from human cord blood (USSC) was analyzed.
Methodology/Principal Findings: Expression profiling revealed downregulation of microRNAs miR-17, -20a, and -106b in
USSC differentiated into neuronal lineage but not in USSC differentiated into osteogenic lineage. Transfection experiments
followed by Ki67 immunostainings demonstrated that each of these microRNAs was able to promote proliferation of native
USSC and to prevent in part cell cycle arrest during neuronal lineage differentiation of USSC. Bioinformatic target gene
predictions followed by experimental target gene validations revealed that miR-17, -20a, and -106b act in a common
manner by downregulating an overlapping set of target genes mostly involved in regulation and execution of G1/S
transition. Pro-proliferative target genes cyclinD1 (CCND1) and E2F1 as well as anti-proliferative targets CDKN1A (p21), PTEN,
RB1, RBL1 (p107), RBL2 (p130) were shown as common targets for miR-17, -20a, and -106b. Furthermore, these microRNAs
also downregulate WEE1 which is involved in G2/M transition. Most strikingly, miR-17, -20a, and -106b were found to
promote cell proliferation by increasing the intracellular activity of E2F transcription factors, despite the fact that miR-17, -
20a, and -106b directly target the transcripts that encode for this protein family.
Conclusions/Significance: Mir-17, -20a, and -106b downregulate a common set of pro- and anti-proliferative target genes
to impact cell cycle progression of USSC and increase intracellular activity of E2F transcription factors to govern G1/S
transition.
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Introduction
Unrestricted somatic stem cells (USSC) from human cord blood
constitute a rare CD45-negative population capable of inducible
homogenous in-vitro differentiation into all three germinal layers
[1,2]. Additionally, using a cocktail of growth and differentiation
factors (XXL-medium), differentiation of USSC into cells of
neuronal lineage (XXL-USSC) expressing neurofilament and
sodium channel proteins was obtained [3]. Furthermore, XXL-
USSC display certain neurotransmitter phenotypes including
expression of GABA [1], dopamine and tyrosine hydroxylase
(TH), the key enzyme of the dopaminergic pathway [3]. Yet this
neuronal lineage differentiation of USSC appears to be limited
since patch-clamp analyses failed to detect voltage activated fast
inactivating Na
+ current [1,3], indicating that XXL-USSC have
not yet developed a fully functional neuronal phenotype.
Nevertheless, cultured USSC rapidly stop proliferation upon
addition of XXL-medium and such cell cycle exit events are
inherently connected to neurogenesis [4].
As a series of coordinated events, the cell cycle consists of
distinct phases namely S, M, G1, and G2. Regulation of the cell
cycle is performed by a phosphorylation cascade involving cyclin/
CDK complexes and three restriction checkpoints, G1/S, G2/M
and metaphase, which sense flaws in critical stages and
subsequently stall cycle progression [5,6]. Transition from G1 to
S phase is governed by E2F transcription factors [7] under
inhibitory influence of hypophosphorylated retinoblastoma pro-
teins (RB1, RBL1, RBL2, [8]). Retinoblastoma proteins are
phosphorylated by Cyclin D1/CDK4/6 complexes [9], which in
turn are targets for negative regulation from a variety of effectors
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family [11].
MicroRNAs have received emerging attention over the last
years as negative regulators of translation. They constitute a
subpopulation of small RNAs of on average 22 nucleotides in
length and are initially transcribed as primary microRNAs
followed by a two step processing into mature microRNAs and
incorporation into the RNA-induced silencing complex (RISC)
[12,13,14,15,16]. MicroRNAs downregulate their target-mRNAs
by sequence-specific base-pairing with their 39-untranslated
regions (39-UTRs) [17,18,19,20,21] and act as key regulatory
molecules in various cellular processes like proliferation, differen-
tiation, apoptosis and metabolism [22,23,24,25,26].
MicroRNAs also appear as important regulators of cell cycle
events [27,28]. In course of molecular G1/S transition regulation,
complex relationships including direct microRNA-mRNA inter-
actions and activation of microRNA transcription exist between
E2F transcription factors [29,30,31] and microRNAs of the miR-
17-92 cluster, one of the most intensively characterized microRNA
families. Including paralogs, this family consists of miR-17, -18,
-19a, -19b, -20a, and -92 (located within a region of 1 kb on
chromosome 13), of miR-106a, -19b, -363, and -92 (X-
chromosomal) and of miR-106b, -93, and -25 (on chromosome
7) [32]. The miR-17-92 cluster regulates mouse stem cell
differentiation [33] and has regulatory potential in leukemia stem
cells [34], and stemness genes like CDKN1A and CDKN1C as
well as PTEN have been proposed as putative targets [35].
Contradictionary findings about miR-17 functions within cell
cycle regulation have been described. Pro-proliferative function
has been reported in HEK293T cells and in lymphocytes [36,37]
but an anti-proliferative function has been observed in human
breast cancer cells [38]. On the other hand, miR-106b, which
shares high sequence homology with miR-17 and miR-20a, was
shown to promote cell cycle progression by targeting CDKN1A
(also termed p21, [39]). CDKN1A is also targeted by microRNAs
of the miR-17-92 cluster [40]. Certain other microRNAs including
miR-24, -34a-c, -124, -137, -195, -214, -221, -222, and -372 are
also involved in cell cycle regulation at G1/M transition as well as
at G2/M transition (reviewed in [27]).
Here we analyzed the impact of the microRNAs miR-17, -20a,
and -106b on cell cycle arrest connected to neuronal lineage
differentiation of USSC induced by retinoic acid containing
neuronal induction medium XXL. These three microRNAs were
found specifically downregulated in XXL-USSC but not in USSC
differentiated into osteogenic lineage, which show no cell cycle
arrest. Target predictions combined with experimental validations
demonstrated that these three microRNAs share a set of target
genes of pro- and anti-proliferative nature. We further show that
miR-17, -20a, and -106b act in a pro-proliferative manner in
USSC and are in part capable to prevent XXL-USSC from cell
cycle arrest. In addition, reporter analyses demonstrate an
increasing effect of these microRNAs on the activity of E2F
transcription factors.
Results
Different regulation patterns of microRNAs miR-17, miR-
20a, and miR-106b during neuronal lineage and
osteogenic differentiation of USSC
To analyze the impact of microRNAs on cell cycle arrest
observed during XXL-mediated neuronal linage differentiation of
USSC we compared microRNA expression profiles of XXL-
induced USSC with those of USSC induced to osteogenic
differentiation. In contrast to neuronal lineage differentiation,
DAG-induced osteogenic differentiation of USSC is not coupled
with a harsh cell cycle arrest and strong apoptotic events. To
analyze and compare microRNA expression, USSC lines SA5/03,
SA5/73, and SA8/25 (generated from different donors and
serving as biological replicates) were differentiated for 14 days
(SA8/25: 14 and 28 days) into neuronal lineage using XXL-
medium as described by Greschat and coworkers [3], and USSC
lines SA5/73 and SA8/25 were differentiated into osteogenic
lineage for 7 days by induction with DAG as described by Ko ¨gler
and coworkers [1]. MicroRNA expression profiles of native and
differentiated USSC of both lineages were determined using the
TaqMan microRNA Megaplex qPCR array [41]. As depicted in
Fig. 1A, microRNAs miR-17, -20a, and -106b were consistently
downregulated up to 10-fold in all XXL-induced USSC lines
tested, whereas their expression remained nearly unchanged or
was found slightly upregulated in both USSC lines induced to
osteogenic lineage (Fig. 1B). Raw qPCR data are shown in Fig. S2.
Although the qPCR assay displays high specificity [41], unspecific
hybridization of primers or the TaqMan probe between the highly
homologous miR-17, -20a, and -106b (Fig. S1) could not be
excluded. We thus analysed expression of these microRNAs in
native USSC lines SA5/73, SA8/25, SA8/77 and SA4/101
employing a deep sequencing approach and independent
expression of miR-17, -20a, and -106b (Fig. S2) in all USSC
analysed was detectec here which points to no or only minor
unspecific effects of the qPCR assay regarding these microRNAs.
MiR-17, miR-20a, and miR-106b have common target
proteins
Since sequences of miR-17, -20a, and -106b are highly
homologous especially with identical seed sequences (Fig. S1), we
reasoned that they could act on common target proteins associated
with cell cycle regulation. We thus performed extensive target gene
predictions using the UNION and the INTERSECTION mode
offered by the web-based prediction machine DIANA miRGen
[42]. UNION summarizes all predictions from the implemented
algorithms, whereas INTERSECTION lists all predictions from
algorithms PicTar AND TargetScanS. Lists of predicted proteins
were loaded into the DAVID database [43] and analyzed for Gene
Ontology (GO) using the search terms cell cycle and prolif. As seen in
Fig. S3, all three microRNAs analyzed share most of the proteins
predicted by miRGen’s INTERSECTION mode, with only miR-
17 lacking a few predicted targets. Predictions using the UNION
mode of miRGen add additional proteins, but the large overlap of
predicted targets between the three microRNAs remains. These
findings suggest a common biological function of miR-17, -20a,
and -106b with respect to cell cycle regulation. Interestingly, pro-
proliferative as well as anti-proliferative proteins are found among
putative target genes.
To test, whether the three microRNAs share their biological
target proteins beyond the level of bioinformatic prediction, 11 pro-
and anti-proliferative proteins from the candidates shown in Fig. S3
covering 33 individual predictions were experimentally validated
(Table 1). Namely the pro-proliferative cyclins CCND1 and
CCND2, transcription factors E2F1 and E2F3, and the anti-
proliferative cyclin D1/CDK4/6-inhibitors CDKN1A and PTEN,
retinoblastoma proteins RB1, RBL1, RBL2, and the G2/M
transition inhibitor WEE1 [44,45,46,47,48] were analyzed. Some
of these proteins (marked with an asterisk in Table 1) have already
been validated as targets of miR-17, -20a and/or -106b (CCND1
[38], CDKN1A [39,40,49], E2F1 [29,30,31,49], E2F3 [30], PTEN
[37], RBL2 [50]) but for reasons of comparability we included them
in our experiments. In addition, we analyzed the anti-proliferative
MAPK9 not found within the GO-Terms-based list but known as a
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activator JUN [51]. For experimental target gene validations, full-
length 39-UTRs or fragments of 39-UTRs (see Table S1) of
transcripts of proteins of interest were cloned at the C-terminus of
Firefly luciferase present in dual luciferase (Firefly/Renilla) reporter
vector pmirGLO. Pairs of empty pmirGLO and pmirGLO/39-
UTRwerecotransfected intoHEK293T cellswithmiR-17, -20a,or
-106b microRNA-mimics to test for specific influence of the
microRNA on the given 39-UTR. Firefly activities were normalized
to effects caused by (i) endogenous HEK293T microRNAs on the
39UTRs cloned (miR-17, miR-20a, and miR-106b and homologs
are highlyexpressed in HEK293T cells[52]), (ii) unspecificeffects of
certain microRNA-mimics on Firefly and Renilla activity per se,a n d
(iii) transfection efficiency variations. Percent reductions of normal-
ized Firefly activities of co-transfections of each mimic with
pmirGLO/39-UTR compared to pmirGLO are given in Fig. 2A–
C. The effects of an unspecific negative control microRNA mimic
on all tested 39-UTRs are summarized in Fig. S4.
Fig. 2A demonstrates that, with the exception of E2F3 and
MAPK9, miR-17 significantly influences all target genes tested
irrespective of an activating or inhibiting function in cellproliferation.
Among the pro-proliferative targets, the strongesteffectswere seen for
CCND1 (appr. 47% reduction in normalized Firefly activity) and
E2F1 (29% reduction). RBL2 and CDKN1A showed the strongest
reductions in activity among the set of anti-proliferative proteins
tested (52% and 30% respectively). As seen in Figs. 2B and 2C, miR-
20a and miR-106b showed highly similar behavior compared to
miR-17 regarding significant Firefly activity reductions and relative
influences between the analyzed target genes. Overall, these results
demonstrate that miR-17, -20a, and -106b not only share a set of
common cell cycle associated target genes on the level of
bioinformatic predictions but also show highly comparable results
Figure 1. Differential expression of miR-17, miR-20a, and miR-106b in USSC differentiating in neuronal and osteogenic lineages.
USSC lines SA5/03, SA5/73, and SA8/25 were differentiated into neuronal lineage for 14 days (SA8/25: 28 days) and USSC lines SA5/73 and SA8/25
were differentiated into osteogenic lineage for 7 days. MicroRNA expression profiles were analyzed from native USSC lines as well as from USSC
differentiated into both lineages using the TaqMan microRNA Megaplex array. Fold expression changes (2
2ddCt-values) are given for microRNAs miR-
17, miR-20a, and miR-106b. (A) Downregulation of miR-17, miR-20a, and miR-106b during neuronal lineage differentiation of USSC. Individual results
from overall 5 independent neuronal lineage differentiation approaches of USSC lines SA5/03, SA5/73 and SA8/25 are given. MicroRNAs miR-17, miR-
20a, and miR-106b were found consistently downregulated in all USSC lines differentiated into cells of neuronal lineage. (B) Expression of miR-17,
miR-20a, and miR-106b during independent osteogenic differentiations of USSC lines SA5/73 and SA8/25. In contrast to the neuronal lineage
differentiations, expression of miR-17, miR-20a, and miR-106b remained unchanged or was slightly upregulated after 7 days of osteogenic
differentiation.
doi:10.1371/journal.pone.0016138.g001
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affect pro- as well as anti-proliferative target proteins.
Functional effect of miR-17, miR-20a, and miR-106b on
cell cycle arrest in XXL-differentiating USSC
Since miR-17, -20a (both encoded on the same transcript), and -
106b were not only found commonly downregulated in XXL-
USSC but also share their target proteins, we chose to analyze the
functional impact of these microRNAs on XXL-induced cell cycle
arrest. To this end USSC SA5/03 were transfected with
37.5 pmol of an equimolar batch of miR-17-, -20a-, and -106b-
mimics, subsequently induced to neuronal lineage by usage of
XXL and immunostained for expression of Ki67 antigen before
and 24 h after XXL-induction. Ki67 is a nuclear protein
expressed by proliferating cells in all stages of the active cell cycle
(G1, S, G2, M) but is absent in resting (G0) cells. To collect
statistically substantial data, 1500–3000 individual cells per
experimental condition from randomly taken photographs of
Ki67-stained cells were counted for Ki67 expression. As shown in
Fig. 3A, the percentage of Ki67-positive cells increased 24 h after
transfection as compared to untransfected cells or those transfected
with an unspecific negative control mimic. Twenty-four hours
after XXL-induction (and 48 h after transfection), the overall
portion of Ki67-positive cells decreased dramatically in untrans-
fected cells and negative-control-transfected cells but was elevated
in cells transfected with the miR-17/-20a/-106b-mimic-batch.
Fig. 3B shows the results of two independent biological
experiments with each three technical replications per experimen-
tal condition. Approximately 50% of untransfected USSC were
found Ki67-positive before and 24 h after transfection and no
significant difference was seen between untransfected and
negative-control-transfected cells. Transfection of the mimic batch
resulted in a significant increase of Ki67-positive cells to $70% of
uninduced cells counted. The XXL-induced cell cycle arrest was
reflected in a strong drop down of Ki67 expression to
approximately 13% Ki67-positive cells 24 h after induction. A
strong and significant increase in Ki67 expression was seen upon
transfection of the mimics-batch compared to both, negative-
control transfected and untransfected cells (Fig. 3B). Taken
together, these data demonstrate that a batch of miR-17, -20a,
and -106b increases the proliferation rate of USSC and in part
prevents them from XXL-induced cell cycle arrest.
The inverted experimental design analyzing the impact of
microRNA inhibitors instead of microRNA mimics on native
USSC showed results fully in line with the aforementioned
observations (Fig. 3A and B). Analyzing 1500–3000 randomly
photographed cells per experimental condition from each of three
independently transfected wells, transfection with 37.5 pmol of an
equimolar batch of miR-17-, -20a-, and -106b-inhibitors resulted
in a marked decrease of Ki67-positive cells 24 h after transfection
as compared to untransfected and negative-control-transfected
cells (Fig. 4A and B). A slightly stronger decrease in Ki67-positive
cells was observed 48 h after transfection. Replacement of the
inhibitor batch by each 37,5 pmol of individual miR-17-, -20a,
and -106b-inhibitors and counting two biological replicates with
three independently transfected wells each demonstrated, that
each of the three microRNA-inhibitors alone was sufficient to
fullfill the inhibitory effect on proliferation of USSC with identical
efficiency as compared to the combined inhibitor-batch (Fig. 4B).
A batch of miR-17, miR-20a, and miR-106b increases E2F
transcription factor activity in HEK293T cells
Although we have demonstrated a pro-proliferative effect of
microRNAs miR-17, -20a, and -106b in USSC, these microRNAs
regulate the expression of pro- as well as anti-proliferative target
genes in parallel. Especially transcription factor E2F1 was among
the most efficiently targeted pro-proliferative proteins identified for
the three microRNAs despite transcription factors from the E2F
family being major governors of G1/S transition. We thus
analyzed the impact of miR-17, -20a, and -106b not on the sheer
presence but on the activity of E2F transcription factors using a Firefly
luciferase reporter driven by a minimal promoter element
consisting of a TATA box and a repeat of six E2F-responsive
elements. HEK293T cells were co-transfected with this E2F-
responsive Firefly reporter (plus a Renilla reporter vector) together
with 3 pmol of an equimolar batch of miR-17-, -20a-, and -106b-
inhibitors or with 3 pmol of each of miR-17-, -20a-, or -106b-
inhibitors alone. As shown in Fig. 5 the E2F-activity strongly
decreased upon addition of the inhibitor-batch compared to the
unspecific negative control of the E2F-reporter alone. Interesting-
ly, when testing each 3 pmol of the individual inhibitors alone,
only the miR-106b-inhibitor was able to strongly downregulate
E2F-activity, whereas the miR-20a-inhibitor showed only moder-
ate effects and the miR-17-inhibitor did not affect E2F activity.
Discussion
MicroRNAs miR-17, -20a, and -106b were consistently found
downregulated in neuronal-specific XXL-USSC but their expres-
sion remained nearly unchanged during osteogenic differentiation
of USSC. These three microRNAs share high homology within
their seed regions, which strongly impacts target mRNA
recognition [53,54], as well as in their 39-regions (Fig. S1). This
implies joint acting of miR-17, -20a, and -106b and consequently,
these microRNAs share a large amount of predicted target genes
involved in cell cycle events (Fig. S3). Interestingly, these putative
targets include both mRNAs of pro-proliferative as well as anti-
proliferative proteins, some of which have already been established
as targets for miR-17, -20a or -106b (Table 1), using a variety of
different reporter gene assays. We chose a group of putative target
genes mostly involved in G1/S transition for our target validations
Table 1. Cell-cycle related proteins predicted as targets for
miR-17, miR-20a, and miR-106b and chosen for experimental
target gene validation.
hsa-miR-17: hsa-miR-20a: hsa-miR-106b:
proproliferative:
CCND1* CCND1 CCND1
CCND2 CCND2 CCND2
E2F1* E2F1* E2F1*
E2F3 E2F3* E2F3
antiproliferative:
CDKN1A* CDKN1A* CDKN1A*
MAPK9* MAPK9 MAPK9
PTEN* PTEN PTEN
RB1 RB1 RB1
RBL1 RBL1 RBL1
RBL2* RBL2 RBL2
WEE1 WEE1 WEE1
Predictions already validated in scientific literature are denoted by an asterisk
(*, see main text for details).
doi:10.1371/journal.pone.0016138.t001
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genes previously validated in the scientific literature. We did not
clone small oligonucleotides spanning only a particular microRNA
target site into pmirGLO and also avoided CMV-promoter-driven
reporter constructs since in our experience these tend to give false
negative results, likely due to prediction errors with regard to the
particular microRNA binding site and saturation of the intracel-
lular protein synthesis machinery, respectively.
We were able to validate pro-proliferative proteins like, e.g.,
CCND1 and E2F1 as well as anti-proliferative proteins like all
three retinoblastoma proteins analyzed (RB1, RBL1, and RBL2)
and WEE1 as targets for all three microRNAs tested. As could be
expected from sequence homologies, miR-17, -20a, and -106b all
had comparable effects on the target 39-UTRs tested. For the first
time we identified CCND2, RB1, RBL1, and WEE1 as targets
common to all three microRNAs and in addition found new
interactions between miR-20a and -106b and CCND1, PTEN,
and RBL2. In addition we were able to confirm most of the targets
already described for miR-17, -20a, and -106b. Despite their cell
cycle relevant target proteins, miR-17, miR-20a, and miR-106b
also impact neuronal lineage differentiation of USSC, since certain
genes relevant for neuronal differentiation and function like
NBEA, EPHA4, NTN4 and NEUROG1 are also affected by these
microRNAs [55]. Since cell cycle arrest and neuronal differenti-
ation are linked together [4], this observation suggests a
coordinated microRNA impact on both cellular processes.
For a comprehensive overview, Fig. 6 summarizes the
relationships between microRNAs miR-17, -20a, -106b and their
validated targets in the context of G1/S transition. Acting in a
joint, putatively additive manner on pro-proliferative as well as on
anti-proliferative targets, miR-17, -20a, and -106b are integrated
into a complex network of microRNA-protein relations with joint
functionality regarding their target genes, protein-protein-interac-
tions and protein-microRNA gene interactions. In general, these
three microRNAs target more anti- than pro-proliferative proteins,
but their inhibiting effects of pro-proliferative CCND1 and E2F1
were among the strongest effects found within our assays.
By Ki67 expression analysis we demonstrated that these
microRNAs are able to override at least in part XXL-mediated
cell cycle arrest in neuronal lineage differentiated USSC and
clearly act in a proproliferating manner. Interestingly, not only the
combined equimolar batch, but also each of these microRNAs
alone was able to manipulate USSC proliferation to a comparable
extent. These observations strongly point to a pro-proliferative
function of each miR-17, -20a, and -106b in USSC and their
participation in cell cycle arrest of XXL-USSC, but are of
somewhat contradictory nature regarding their aforementioned
proproliferating target genes.
As depicted in Fig. 6, G1/S transition is executed by
transcription factors of the E2F family, namely E2F1-3 [7,56],
which bind to E2F-responsive promoters and are integrated in a
complex upstream and downstream regulatory network. Anti-
proliferative proteins like CDKN1A and PTEN inhibit kinase
activity of CCND1/CDK4/6 complexes and thus prevent
phosphorylation of retinoblastoma proteins RB1, RBL1 and
RBL2. Hypophosphorylated retinoblastoma proteins in turn
associate E2F transcription factors and thereby inhibit cell cycle
progression [57,58]. MiR-17, -20a, and -106b target all mentioned
proteins involved in this network, and from the functional
interactions described, one ‘‘final’’ goal of this regulatory pathway
seems to be the control of E2F activity. In turn, E2F not only
activates its own transcription, but is also feed-forward-loop
connected (directly or via MYC) to the transcription of miR-17,
-20a, and -106b, which has been interpreted as tight cell cycle
control mechanism. Using a retroviral overexpression approach of
the miR-17-92 cluster, Yu and coworkers [38] described an anti-
proliferative effect of miR-17 and miR-20a based on their
interaction with CCND1-39-UTR, whereas functional data
provided in our study are in line with the earlier report of pro-
proliferative effects of miR-17 [36]. These contradictory observa-
tions might be explained by a model proposed by Cloonan and
coworkers [36], which is based on the relative abundance of pro-
and anti-proliferative miR-17-targets. This model can now be
extended to miR-20a and miR-106b. It should be noted, however,
that microRNA-mediated intracellular regulation not only de-
pends on the abundance of target proteins but also on the relative
expression levels of targeting microRNAs and their affinity to 39-
UTRs of target-mRNAs. MiR-17 and miR-20a belong to the
medium abundant microRNAs in native USSC and they are
found among the most strongly downregulated microRNAs in
XXL-USSC, together with miR-106b. Interactions of miR-17,
-20a and -106b with CCND1 and RBL2 were among the strongest
found in our assays, whereas other target 39-UTRs showed
significantly weaker responses. Since human breast cancers show
increased abundance of CCND1 [38], CCND1 might serve as a
preferred target in this individual intracellular environment.
In view of these complex relationships, prediction of functional
effects of microRNA expression patterns on cell cycle regulation
remains difficult, particular since activities of certain proteins
involved are regulated by posttranslational modifications or
heterodimerization. Therefore, we directly measured the activity
of E2F transcription factor as the ‘‘executive’’ protein reponse to
inhibition of miR-17, -20a, and -106b and thereby record their
downstream ‘‘net’’ effect on E2F activity caused by the interplay of
their pro- and anti-proliferative targets. Indeed, activity of a
luciferase reporter driven by an E2F-responsive promoter element
was strongly reduced upon addition of an equimolar batch of miR-
17-, -20a-, and -106b-inhibitors in HEK293T cells. Although single
inhibitors were less effective in HEK293T cells than the batch of
three inhibitors together (likely due to different cellular expression
Figure 2. Experimental validation of target gene predictions. Validation of putative cell cycle relevant target genes for microRNAs miR-17 (A),
miR-20a (B), and miR-106b (C) in HEK293T-cells. 39-UTR fragments from putative targets CCND1, CCND2, E2F1, E2F3, CDKN1A, MAPK9, PTEN, RB1,
RBL1, RBL2, and WEE1 were cloned at the 39-end of the Firefly ORF in Firefly/Renilla dual reporter vector pmirGLO. To test the influence of endogenous
microRNAs, pmirGLO and pmirGLO/39-UTR were each transfected into HEK293T-cells. Normalized Firefly-activities were compared to those of pairwise
co-transfections of these vectors with the microRNA mimic of interest (miR-17, miR-20a, miR-106b, also including an unspecific mimic negative
control) to test for (i) unspecific effects of the given microRNA-mimic on Firefly/Renilla per se, (ii) effects of endogenous HEK293T microRNAs (iii) for
validation of the particular target prediction. Dark grey columns show normalized Firefly activities from pmirGLO/39-UTR transfections and pmirGLO +
mimics co-transfections, light grey columns those from pmirGLO/39-UTR + mimics co-transfections. Percent reductions of Firefly activities from co-
transfections of pmirGLO/39-UTR + mimic compared to pmirGLO + mimic are given as mean values from 2 biological experiments, each consisting of
4 technical replicates. Error bars represent standard deviations and statistical significancies (Student’s t-test, unpaired, ***: p#0.001, **: p#0.01) are
given. Effects of the unspecific negative control on pmirGLO and pmirGLO/39-UTR vectors are shown separately in Fig.S2. Except for E2F3 and MAPK9,
all predicted proteins could be validated as statistically significant targets for all three microRNAs tested, although microRNA influence varied from
strong (i.e. RBL2) to moderate (i.e. WEE1).
doi:10.1371/journal.pone.0016138.g002
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PLoS ONE | www.plosone.org 6 January 2011 | Volume 6 | Issue 1 | e16138Figure 3. Proliferation-activating effect of microRNA mimics to miR-17, miR-20a, and miR-106b in USSC. (A) USSC line SA5/03 was
transfected with a negative control mimic or an equimolar batch of miR-17-, -20a-, and -106b-mimics and induced to neuronal lineage differentiation
using XXL–medium 24 h after transfection. Cells were immunostained for proliferation marker Ki67 and DAPI-stained. Ki67 (green)/DAPI stains from
time points 24 h and 48 h after transfection are shown from untransfected SA5/03, and from SA5/03 transfected with negative control mimic and the
mimic batch, respectively. (B) Increase of Ki67 expression in native USSC as well as in XXL-USSC upon miR-17-, -20a- and -106b-mimics-batch
transfection. Combined results from counting of 1500–3000 Ki67/DAPI-stained cells/experimental condition from two biological replicates with 3
technical replicates each are given, together with standard error of the means and statistical significancies (Student’s t-test, unpaired: ***: p#0.001).
doi:10.1371/journal.pone.0016138.g003
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PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e16138levels of miR-17, -20a, and -106b in HEK293T cells and different
crossreactivities of the single microRNA inhibitors and their highly
homologous target-microRNAs (Fig. S1, [59])) this result demon-
strates that the inhibitory effects of three microRNAs on anti-
proliferative proteins obviously overrides their inhibitory effects on
pro-proliferative proteins, especially on E2F1 in HEK293T cells.
Due to technical constraints regarding weak plasmid/microRNA
inhibitors co-transfection efficiencies in USSC, this experiment
could not be performed in USSC, but in view of the results of the
Ki67-experiments (Figs. 3 and 4), we assume that USSC follow the
same regulatory mechanisms as HEK293T cells.
Pickering and coworkers [31] demonstrated an appoximately
2-fold increase of E2F1 levels upon inhibition of miR-17 and
miR-20a in human fibroblasts and a decrease of BrdU–positive
cells upon inhibition of miR-17 and miR-20a in serum starved
fibroblasts. Our observations are in line with these results and
show that microRNAs miR-17, -20a, and -106b can positively
modulate E2F activity despite their direct targeting of E2F1.
MiR-20a also affects translation of E2F2 and E2F3 [30]. Since
E2F1-3 participate in G1/S transition and the E2F reporter assay
does not distinguish between different E2Fs, it remains unclear,
whether miR-17, -20a, and -106b exhibit increasing effects on the
activity of E2F1 only or on all E2Fs involved in G1/S transition.
Nevertheless, the result of the E2F-reporter assay is fully in line
with the pro-proliferative effect caused by miR-17-, -20a-, and
-106b-mimics and the anti-proliferative effect shown by the
miR-17-, -20a-, and -106b-inhibitors in USSC and XXL-USSC,
respectively.
Figure 5. Mir-17, miR-20a, and miR-106b inhibit E2F transcription factor activity. HEK293T-cells were cotransfected with a luciferase
reporter vector containing a Firefly gene driven by a minimal promoter consisting of a TATA-box preceeded by a repeat of six E2F-responsive
elements and pre-mixed with a CMV-promoter driven Renilla luciferase reporter vector (Cignal Reporter Assay, SABiosciences) and an equimolar
batch of miR-17-, -20a-, and -106b-inhibitors as well as with the inibitors alone and with an unspecific negative control respectively. Mean values of
normalized Firefly activities from 2 biological experiments, each consisting of 4 technical replicates are shown for each co-transfection. Error bars
represent standard deviations and statistical significancies (Student’s t-test, unpaired: ***: p#0.001, **: p#0.01) are given. The inhibitor batch strongly
reduced E2F-activity, whereas only miR-20a-, and miR-106b-inhibitor alone gave significant effects on E2F-activity.
doi:10.1371/journal.pone.0016138.g005
Figure 4. Proliferation-inhibiting effects of microRNA inhibitors to miR-17, miR-20a, and miR-106b in USSC. (A) USSC line SA5/03 was
transfected with a negative control inhibitor or an equimolar batch of miR-17-, -20a-, and -106b- inhibitors, as well as with the 3 inhibitors alone. Cells
were immunostained for Ki67 expression and DAPI-stained 24 h and 48 h after transfection. Stains from time points 24 h and 48 h after transfection
are shown from untransfected SA5/03, and from SA5/03 transfected with negative control mimic and the inhibitor batch, as well as with the miR-17,
miR-20a, and miR-106b inhibitors alone (48 h only). (B) Decrease of Ki67 expression in native USSC as well as in XXL-USSC upon miR-17-, -20a- and -
106b-inhibitor transfections. Combined results from counting of 1500-3000 Ki67/DAPI-stained cells/experimental condition performed in two
biological replicates with 3 technical replicates each are given, together with standard error of the means and statistical significancies (Student’s t-
test, unpaired: *: p,0.05, ***: p#0.001). Both experimental designs, usage of microRNA mimics (Fig. 3A and B) and microRNA inhibitors (Fig. 4A
and B), demonstrate a proliferation-activating effect of miR-17, -20a, and -106b in USSC.
doi:10.1371/journal.pone.0016138.g004
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but, in addition, we were also able to identify WEE1 as a target of
miR-17, -20a, and -106b. Negative cell cycle regulator WEE1 is a
nuclear Ser/Thr kinase which deactivates cyclin B/CDK1 to
inhibit the cell cycle at the G2/M transition [48]. Although the
response of WEE1-39-UTR in our target gene validation assay was
weaker than that of CCND1 or RBL2, this finding further
demonstrates, that miR-17, -20a, and -106b can potentially act as
pro-proliferative microRNAs in a coordinated manner at different
regulatory checkpoints of the cell cycle.
The complex network of cell cycle regulation is further
influenced by certain other microRNAs (for an overview see
[27]). Among the negative regulators of CCND1/CDK4/6
dimers, members of the Cip/Kip family are regulated by
microRNAs. Beside CDKN1A (also termed p21), which is targeted
by miR-17, -20a, and -106b ([39,40,49], all confirmed in our
study), p27 and p57 are downregulated by miR-221 and miR-222
[60]. These microRNAs are also found downregulated in XXL-
USSC, as well as miR-137 and miR-214 (Fig. S2), which both
target CDK6 [61,62] In addition to miR-17 [37], miR-20a, and
miR-106b (this study), miR-214 also downregulates PTEN [63].
MiR-34a is found upregulated in XXL-USSC (Fig. S2) and is
known as a negative regulator of CCND1 and CDK6 [64]. In
summary, the differential microRNA expression pattern in USSC
and cell-cycle-arrested XXL-USSC clearly point to an anti-
proliferative miRNA expression pattern in XXL-USSC. This not
only includes the analyzed miR-17, -20a, and -106b, but also
additional microRNAs miR-34a, -137, -214, -221, and -222.
Although each miR-17, -20a, and -106b alone were sufficient to
influence proliferation of USSC and to partly release XXL-USSC
from cell-cycle arrest, the additional microRNAs might play a
supporting role in keeping XXL-USSC from proliferation.
At first view it is a contradictory finding that inhibition of
microRNAs miR-17, -20a, and -106b decreases transcription factor
activity of their validated target gene E2F. This demonstrates that a
simplistic view of microRNAs as molecular switches needs to be
extended to fully understand their molecular function. Rather than
being single switches, target gene redundancy of microRNAs as
described here for miR-17, -20a, and -106b leads to their integration
into complex networks and feedback loops regulating pro- and
antiproliferating targets. In such networks, microRNAs in general
might fullfill finetuning functions and act as rheostats [19] rather than
as molecular switches. Furthermore, target gene redundancy leads to
the finding that microRNAs miR-17, -20a, and -106b not only
function in cell cycle, but in addition impact neuronal lineage
differentiation of USSC together with additional members of the
miR-17-92 cluster and paralogs also found downregulated in XXL-
USSC [55]. Functional description of microRNAs thus not only
requires knowledge of individual microRNA-target gene interactions,
but also of abundance of target genes together with their molecular
interactions. The data presented here that illustrate the complex
interactions within the cell cycle network and help to further
understand microRNA function herein.
Materials and Methods
Neuronal lineage differentiation of USSC
For expansion, USSC were incubated with DMEM (Lonza,
Cologne, FRG) supplemented with 30% heat inactivated foetal
bovine serum (Lonza) and penicillin/streptomycin (100 U/ml,
Figure 6. Relationships between pro-proliferative and anti-proliferative proteins involved in G1/S transition and miR-17, miR-20a,
and miR-106b. Pro-proliferative proteins are shown as green squares, anti-proliferative proteins are given as orange circles. Black lines denote
protein-protein interactions, red lines represent microRNA-protein interactions. Dashed black lines show activatory interactions of proteins on
microRNA genes. *Predicted interactions of miR-17, -20a, and -106b and MAPK9 could not be validated in our assay, but an interaction between miR-
17 and MAPK9 had been shown by Cloonan and coworkers [22].
doi:10.1371/journal.pone.0016138.g006
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tiation was performed as previously described [3]. Briefly, USSC
lines SA5/03, SA5/73, and SA8/25 were seeded on laminin pre-
coated glass cover slips and incubated with differentiation medium
XXL containing DMEM GlutaMAX
TM (Gibco), 15% FBS, U/ml
penicillin/streptomycin, 50 ng/ml beta-NGF, 20 ng/ml bFGF
(both Tebu), 1 mM dibutyryl-cAMP, 0.5 mM 3-isobutyl-methyl-
xanthine and 10 mM all-trans-retinoic acid (all Sigma-Aldrich,
Taufkirchen, FRG) up to 14 days (28 days for SA8/25).
Osteogenic lineage differentiation of USSC
USSC lines SA5/73 and SA8/25 were induced to osteogenic
differentiation as described by [1]. In brief, induction was achieved
by addition of DAG (Dexamethason, ascorbic acid, b-glycerolpho-
sphate) and subsequent incubation for 7 days. Osteogenic
differentiation was verified by Alizarin-Red staining [1].
microRNA expression analysis
Preparation of small and large RNA fractions from native
USSC and USSC differentiated into neuronal and osteogenic
lineages were performed using the Ambion mirVana miRNA
Isolation kit (Applied Biosystems, Darmstadt, FRG) according to
the manufacturer’s instructions, with the sole exception of direct
lysis of adherent USSC, thereby omitting cell trypsinisation.
Small RNA fractions were applied to microRNA expression
analysis by using the TaqMan microRNA Megaplex array (pool
A, Applied Biosystems, Darmstadt, FRG) [41] according to the
manufacturer’s instructions. Briefly, 10 ng of small fraction sample
RNA were reverse transcribed and preamplified for 12 PCR
cycles, with a subsequent TaqMan-probe based array-amplifica-
tion for 40 additional PCR cycles. Raw Ct-values were normalized
to U6 RNA data and ddCt as well as 2
2(ddCt) data were calculated.
Barcoded small RNA sequencing was used to generate miRNA
expression profiles for 4 native USSC lines (SA5/73, SA8/25,
SA8/77, and SA4/101); this method is a modification of an
established small RNA sequencing protocol which involves
sequential ligation of 39 and 59 adapters to small RNAs, followed
by cDNA library preparation, Solexa sequencing, and small RNA
annotation [65].
Computational target gene predictions
Bioinformatic target gene predictions were performed using web
based compilation of several prediction algorithms miRGen
(http://www.diana.pcbi.upenn.edu/miRGen.html). MiRGen was
used in the UNION mode (collection of all predictions from 6
algorithms) as well as in the INTERSECTION mode (presenting
all target genes predicted by algorithms PicTar AND TargetScan),
the latter resulting in less but more reliable predictions. The
DAVID database [43] (issue 2008, http://david.abcc.ncifcrf.gov/
content.jsp?file=fact.html) was used for Gene Ontology and
pathway analysis (linked to the KEGG database, http://www.
genome.jp/kegg/pathway.html) of predicted target genes. Micro-
RNA target gene predictions were further completed using the
algorithms miRanda ([66], http://www.microrna.org/microrna/
home.do), PicTar ([54] http://pictar.mdc-berlin.de/), and Tar-
getScan 5.1 ([17] http://www.targetscan.org/).
Experimental validation of target gene predictions
PCR-products of full length 39-UTRs or fragments of 39-UTRs
covering the predicted microRNA binding sites on the target gene
mRNA of interest were cloned at the 39-end of Firefly luciferase
ORF in dual reporter (Firefly and Renilla luciferases) vector
pmirGLO (GenBank accession FJ376737, Promega, Mannheim,
FRG) using restriction enzyme pairs SacI/XbaI or SalI/XhoI.
Information on PCR-primers, mRNA templates used and UTR
fragment sizes are given in Table S1. To normalize for effects of
endogenous microRNAs of HEK293T on the given 39-UTR, each
100 ng of both pmirGLO vector as well as pmirGLO/39-UTR
were transfected into 5610
4 HEK293T cells using 0.5 ml
Lipofectamine 2000 (Invitrogen, Karlsruhe, FRG). Pairwise
cotransfections of 100 ng empty pmirGLO with the 2.5 pmol
microRNA mimic (Dharmacon, Bonn, FRG) of interest and
pmirGLO/39-UTR with the microRNA mimic of interest were
performed. Firefly and Renilla activities were determined 24 h after
transfection using Beetlejuice and Renillajuice reagents (PJK,
Kleinblittersdorf, FRG). All transfection experiments were per-
formed in at least two independent biological experiments with
quadruple transfections each.
Transfection and immunostaining of USSC
USSC were transfected with microRNA mimics and inhibitors
(both Dharmacon, Bonn, FRG) using Lipofectamine 2000
(Invitrogen, Karlsruhe, FRG) according to the manufacturer’s
instructions. For immunocytochemical analysis of Ki67 expres-
sion, cells on coverslips were fixed with 4% formaldehyde (Merck,
Darmstadt, FRG) for 10 min, rinsed three times with PBS and
incubated with blocking solution including 10% normal goat
serum and 0,03% Triton X-100 for 1 h. Cells were incubated with
mouse monoclonal a-Ki67 antibody (1:500, Chemicon, Schwal-
bach, FRG) and the Alexa 594 conjugated a-mouse secondary
antibody (1:500, Invitrogen). Cell nuclei were labelled with 4,69-
diamidino-2-phenylindoline (DAPI, Roche Diagnostics, Mann-
heim, FRG). As negative controls and to ensure specificity first
antibody was omitted. Photographs were taken from randomly
chosen sectors of three independently transfected wells and
.1500 cells per experimental condition were counted for Ki67
expression.
E2F reporter assay
HEK293T cells were cotransfected with 100 ng of E2F-
responsive Cignal-vector (SA Biosciences/Qiagen, Hilden, FRG),
premixed 40:1 with a CMV-promoter-driven Renilla normalization
vector) and 3 pmol of microRNA inhibitors (or 3 pmol of an
equimolar batch). Firefly and Renilla activities were determined
24 h after transfection using Beetlejuice and Renillajuice reagents
(PJK, Kleinblittersdorf, FRG).
Supporting Information
Figure S1 Sequence Aligning between miR-17, miR-20a,
and miR-106b. The grey box shows the seed regions which are
identical in all three microRNAs. Percentages of homology
between individual microRNAs are given.
(TIF)
Figure S2 Raw microRNA expression data. This Excel file
is divided into three sheets ‘‘Neuronal diff.’’, ‘‘Osteogenic diff.’’,
and ‘‘Deep sequencing’’. ‘‘Neuronal diff.’’ gives Ct, dCt, ddCT as
well as 2
2(ddCt)-values from neuronal lineage differentiations of
USSC lines SA5/03 (3 independent differentiations) SA5/73, and
SA8/25 generated by the TaqMan qPCR-assay. Expression data
of microRNAs miR-17, miR-20a, and miR-106b and additional
cell-cycle-related microRNAs are shown from native USSC as well
as from days 14 and 28 (SA8/25) of differentiations. ‘‘Osteogenic
diff.’’ gives the TaqMan qPCR-assay data from osteogenic
differentiations of USSC SA5/73 and SA8/25 at days 0 (native)
and 7. ‘‘Deep sequencing’’ gives deep sequencing expression data
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PLoS ONE | www.plosone.org 11 January 2011 | Volume 6 | Issue 1 | e16138of microRNAs miR-17, miR-20a, and miR-106b aquired from
native USSC lines SA5/73, SA8/25, SA8/77, and SA4/101.
Number of sequence reads as well as expression frequencies are
shown.
(XLS)
Figure S3 List of cell-cycle related genes predicted as
targets for miR-17, miR-20a, and miR-106b. Total
predictions from the DIANA prediction tool (http://www.diana.
pcbi.upenn.edu/miRGen.html) were filtered using GO terms
CELL CYCLE and PROLIF by using the DAVD database
(http://david.abcc.ncifcrf.gov/tools.jsp). UNION shows all pre-
dictions from all algorithms implemented in the DIANA tool,
INTERSECTION shows targets predicted by algorithms PicTar
AND TargetScanS within the DIANA webtool.
(XLS)
Figure S4 Summary of effects of an unspecific negative
control on each 39-UTR used in target validations. For
details refer to Fig. 2. Mean values from 2 biological experiments,
each performed in 4 technical replicates are given. Error bars
represent standard deviations and statistical significancies (Stu-
dent’s t-test, unpaired, *: p#0.05) are indicated. No significant
effect of the unspecific control on any pmirGLO/39UTR
compared to pmirGLO was observed, except for PTEN, where
a minor upregulation of normalized Firefly activity was observed.
(TIF)
Table S1 Overview of cloned 39-UTRs. A summary of Gene
Bank accession numbers, PCR-primers, lengths of 39-UTRs and
cloned fragments thereof used for validations of predicted target
genes is given. Restriction enzyme recognition sites are denoted in
bold.
(XLS)
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